Purple Biotech Updates Corporate Presentation
Ticker: PPBT · Form: 6-K · Filed: Jul 10, 2025 · CIK: 1614744
Sentiment: neutral
Topics: corporate-update, presentation, 6-K
TL;DR
Purple Biotech dropped a new deck on 7/10/25 - check it for updates.
AI Summary
On July 10, 2025, Purple Biotech Ltd. released an updated corporate presentation titled "Purple Biotech Corporate presentation July 2025". This filing is a Report of Foreign Private Issuer under the Securities Exchange Act of 1934.
Why It Matters
This updated presentation likely contains new information regarding the company's pipeline, strategy, or financial performance, which could influence investor decisions.
Risk Assessment
Risk Level: low — This filing is a routine corporate update and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- Purple Biotech Ltd. (company) — Registrant
- July 10, 2025 (date) — Date of presentation release
- Purple Biotech Corporate presentation July 2025 (document) — Title of updated presentation
- 001-37643 (filing_id) — SEC Commission File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report the issuance of an updated Company presentation, "Purple Biotech Corporate presentation July 2025", as required for a Foreign Private Issuer.
When was the updated corporate presentation released?
The updated corporate presentation was released on July 10, 2025.
What is the SEC Commission File Number for Purple Biotech Ltd.?
The SEC Commission File Number for Purple Biotech Ltd. is 001-37643.
What is the SIC code for Purple Biotech Ltd.?
The Standard Industrial Classification (SIC) code for Purple Biotech Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Does Purple Biotech Ltd. file annual reports under Form 20-F or Form 40-F?
Purple Biotech Ltd. files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 10, 2025 regarding PURPLE BIOTECH LTD. (PPBT).